Circadian biomarkers such as melatonin and clock gene, and the neurological processes underlying circadian rhythm, are altered by not only the neurodegeneration of PD, but also dopaminergic treatments used to mitigate parkinsonian symptoms [20]. This evidence concerns the gene CLOCK and Parkinson disease.